Vemedia (PRIVATE.VEMEDIA)

Overall impact
B (73)

Commentary

Vemedia is a strong overall performer. With a 'B' rating of 73.4 for overall impact (87th percentile compared to all companies), Vemedia ranks 38th out of 154 industry peers, behind Adamis Pharmaceuticals, Benitec Biopharma, Aquinox Pharmaceuticals and 34 others, and ahead of Assertio Therapeutics, Evolus, DiaMedica Therapeutics and 113 others. On top material causes for Vemedia's industry (Pharmaceuticals & Biotech), Vemedia performs well in Child and Maternal Health (95.0 score), Child and Maternal Health (95.9), Access to Affordable Healthcare (91.4) and 4 other causes where it received an 'A' score and performs poorly in Decent, Safe Work Opportunities (36.8 score).
Impact
Cause PRIVATE.VEMEDIA
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1961
Employees
60
Sector
Health Care
Industry
Pharmaceuticals
Sub-industry
Pharmaceuticals
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Netherlands
Share classes
PRIVATE.VEMEDIA
Description
Manufacturer of health products and pharmaceutical ingredients. The company specializes in the production of tablets, film-coated tablets and capsules in bottles or blister packs. The company also produces dosed packaging for liquids and drug ingredients.
Material causes
Ethos considers the following causes material for Vemedia, based on its industry sub-industry Pharmaceuticals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.